Effects of Metoclopramide and Goserelin on Tumor Growth in Rats
Author Information
Author(s): Vegh Irene, de Salamanca Rafael EnrĂquez
Primary Institution: Centro de Investigacion, Hospital Universitario 12 de Octubre, Madrid, Spain
Hypothesis
Does metoclopramide administration affect the development of nitroso-N-methylurea-induced tumors in rats, and how does goserelin treatment influence prolactin, TNF alpha, and nitric oxide expression?
Conclusion
Metoclopramide accelerates tumor growth, while goserelin administration inhibits tumor development and reduces levels of prolactin, TNF alpha, and nitric oxide.
Supporting Evidence
- Metoclopramide treatment increased tumor incidence to 85%.
- Goserelin administration resulted in significant inhibition of plasma prolactin levels.
- Nitric oxide levels were significantly higher in rats with induced tumors compared to healthy controls.
Takeaway
This study found that a medicine called metoclopramide makes tumors grow faster in rats, but another medicine called goserelin can help slow down or stop that growth.
Methodology
Female Wistar rats were treated with nitroso-N-methylurea to induce tumors, followed by administration of metoclopramide and goserelin to assess their effects on tumor growth and related biomarkers.
Potential Biases
Potential bias in the selection of treatment groups and the interpretation of results due to the experimental design.
Limitations
The study was conducted on a specific strain of rats, which may limit the generalizability of the findings to other models or species.
Participant Demographics
Female Wistar rats, aged 55 days at the start of the experiment.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website